Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

FLUAR - A novel solution for fluorescence-guided surgery based on augmented reality

Project description

Special glasses to improve cancer surgery

Cancer surgery demands precise tumour removal, yet current methods relying on fluorescence-guided surgery (FGS) suffer from subjective image interpretation. This can lead to errors and prolonged procedures. Surgeons struggle to accurately match images to the body, impacting the completeness of tumour removal and patient outcomes. This inefficiency increases operating times and costs, thereby increasing the burden on healthcare systems. In this context, the EIC-funded FLUAR project introduces augmented reality glasses equipped with NIR sensors and computer vision algorithms. With over 2.8 million operations performed annually, FLUAR promises to revolutionise cancer surgery, enhancing precision and patient outcomes. This project aims to finalise and validate FLUAR’s technical advancements and clinical applicability, thus addressing critical needs in cancer care.

Objective

Fluorescence-guided surgery (FGS) uses near-infrared (NIR) sensors to detect and display fluorescent biomarkers indicating the exact location of tumors. But the current cameras and monitors force surgeons to match the images to the body via subjective comparisons. This long, error-prone process reduces the accuracy, and increases operating times and cost. This is a critical problem in cancer surgery where complete tumor removal is key to prevent recurrence, e.g. a yearly incidence of <0.5 M breast cancer patients requires over 2.8 M surgeries.
FLUAR are novel augmented reality (AR) glasses with integrated high-end NIR sensors and computer vision algorithms. They detect and display the fluorescent biomarkers in the surgeons’ direct sight, hence show the tumor margins on the target. FLUAR will increase the surgeons’ accuracy and reduce tumor removal times. This project aims to finalize and validate FLUAR’s technical developments and clinical usability according to end-user requirements.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2022-ACCELERATOR-01

See all projects funded under this call

Coordinator

ARSPECTRA S.A.R.L.
Net EU contribution
€ 2 458 000,00
Address
20 RUE DU COMMERCE
3895 Mondercange
Luxembourg
SME
Yes
Region
Luxembourg Luxembourg Luxembourg
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 3 514 695,00